[HTML][HTML] Translation rates and protein folding
The mRNA coding sequence defines not only the amino acid sequence of the protein, but
also the speed at which the ribosomes move along the mRNA while making the protein. The …
also the speed at which the ribosomes move along the mRNA while making the protein. The …
Translation of in vitro-transcribed RNA therapeutics
T von der Haar, TE Mulroney, F Hedayioglu… - Frontiers in Molecular …, 2023 - frontiersin.org
In vitro transcribed, modified messenger RNAs (IVTmRNAs) have been used to vaccinate
billions of individuals against the SARS-CoV-2 virus, and are currently being developed for …
billions of individuals against the SARS-CoV-2 virus, and are currently being developed for …
Implementing computational methods in tandem with synonymous gene recoding for therapeutic development
BC Lin, NM Kaissarian, C Kimchi-Sarfaty - Trends in Pharmacological …, 2023 - cell.com
Synonymous gene recoding, the substitution of synonymous variants into the genetic
sequence, has been used to overcome many production limitations in therapeutic …
sequence, has been used to overcome many production limitations in therapeutic …
Blood coagulation factor IX: structural insights impacting hemophilia B therapy
Coagulation factor IX plays a central role in hemostasis through interaction with factor VIIIa
to form a factor X–activating complex at the site of injury. The absence of factor IX activity …
to form a factor X–activating complex at the site of injury. The absence of factor IX activity …
Investigating the impact of synonymous gene recoding on a recombinantly expressed monoclonal antibody under different process parameters
NM Kaissarian, SL Sandefur, A Ghosh… - Bioengineering & …, 2025 - Wiley Online Library
Monoclonal antibodies (mAbs) are commonly used biologic therapeutics with a wide variety
of clinical applications. During the development process, manufacturers consider different …
of clinical applications. During the development process, manufacturers consider different …
A kinetic model for compound heterozygous pathogenic variants in Tyrosyl-tRNA synthetase gene YARS2-Associated neonatal phenotype
T Christian, S Maharjan, S Yin, Y Yamaki… - Journal of Biological …, 2025 - jbc.org
Human genetic disorders are often caused by mutations of compound heterozygosity, where
each allele of the mutant gene harbors a different genetic lesion. However, studies of such …
each allele of the mutant gene harbors a different genetic lesion. However, studies of such …
Study on the Mutation of FⅨ Gene in 31 Patients with Type B Hemophilia
D Liu, R Guo, M Chen, B Shi… - Clinical and Applied …, 2024 - journals.sagepub.com
Hemophilia B (HB) is an inherited bleeding disorder caused by defects in the FⅨ gene,
leading to severe coagulation dysfunction. This study designed eight pairs of primers …
leading to severe coagulation dysfunction. This study designed eight pairs of primers …
Noise-Reduction and Sensitivity-Enhancement of a Slee** Beauty-Based Tet-On System
Tetracycline-inducible systems are widely used control elements for mammalian gene
expression. Despite multiple iterations to improve inducibility, their use is still compromised …
expression. Despite multiple iterations to improve inducibility, their use is still compromised …
[PDF][PDF] Research on Synthetic Genomes
L Hoogerland, FB dos Santos, ML Bilgin, TNV Saaki… - 2024 - government.nl
The possibility of constructing synthetic genomes represents a groundbreaking frontier in
synthetic biology, enabling researchers to design, build, and manipulate genetic material in …
synthetic biology, enabling researchers to design, build, and manipulate genetic material in …
Mécanismes d'échappement des cellules tumorales mammaires au contrôle hormonal: étude de l'impact du biais d'usage des codons
L Clusan - 2022 - theses.hal.science
Le cancer du sein est le cancer le plus diagnostiqué dans le monde, et le plus meurtrier
chez la femme. 70% des cas sont caractérisés par l'expression du récepteur aux …
chez la femme. 70% des cas sont caractérisés par l'expression du récepteur aux …